Product
Amikacin
Aliases
Amikacin Injection
7 clinical trials
9 indications
Indication
Urinary Tract InfectionsIndication
DrugIndication
Pulmonary Disease Due to MycobacteriaIndication
Bladder CancerIndication
Urologic Surgical ProceduresIndication
TuberculosisIndication
Multidrug-resistantIndication
Febrile NeutropeniaClinical trial
Metabolic Potentiation of Aminoglycosides: a Novel Antimicrobial Strategy to Prevent Urinary Tract Infections (UROPOT TRIAL).Status: Recruiting, Estimated PCD: 2025-10-15
Clinical trial
Evaluation of the Incidence of Necrotizing Enterocolitis in Preterm Infants With Respiratory Distress Syndrome Undergoing Caffeine TherapyStatus: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Single Dose Amikacin for Uncomplicated Cystitis in the Emergency Department (ED): A Feasibility StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Randomized Phase II Study of Antibiotic Prophylaxis With Fosfomycin vs Amikacin in Transurethral Resection of BladderStatus: Completed, Estimated PCD: 2023-04-01
Clinical trial
Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis (Stake) Amendment to Study Protocol: "All-oral Shorter Treatment Regimen for Multidrug- and Rifampicin-resistant Tuberculosis (MDR/RR-TB): Evaluating Its Effectiveness, Safety and Impact on the Quality of Life of Patients in Rwanda" (ShORRT)Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaStatus: Recruiting, Estimated PCD: 2026-07-01